December 8, 2006

Nanotechnology: Don’t Delay Liability Risk Assessments And Solutions

Issues:

Combating Litigation Abuse: Civil Justice / Class Actions

Download the PDF

By George J. Mannina, Jr., a Senior Partner at the law firm of O’Connor & Hannan, LLP, and a member of the Environmental Practice Group at the Firm.

In Op-Ed, WLF Advisory Board Member Questions FDA “Crackdown” on Pharma Ads

National Retail Federation v. James

A Threat to M&A Market Vitality: “Break-Up Fee” Taxation in the Pending Appeal of AbbVie v. Comm. of Internal Revenue

Legal Backgrounders

Nanotechnology: Don’t Delay Liability Risk Assessments And Solutions

Medicines And The Environment: Legal And Regulatory Storms Ahead?

U.S. Patent Reform And The Future Of Nanotechnology

Featured

In Op-Ed, WLF Advisory Board Member Questions FDA “Crackdown” on Pharma Ads

Featured Case

National Retail Federation v. James

Featured

A Threat to M&A Market Vitality: “Break-Up Fee” Taxation in the Pending Appeal of AbbVie v. Comm. of Internal Revenue

Legal Backgrounders

Nanotechnology: Don’t Delay Liability Risk Assessments And Solutions

Related Content

Medicines And The Environment: Legal And Regulatory Storms Ahead?

U.S. Patent Reform And The Future Of Nanotechnology